Castle Biosciences
CSTL
CSTL
153 hedge funds and large institutions have $514M invested in Castle Biosciences in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $569M → $514M (-$54.2M)
12% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 26
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
153
Holding in Top 10
3
Calls
$946K
Puts
$153K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$6.66M | |
| 3 | +$6.64M | |
| 4 |
DM
Deerfield Management
New York
|
+$6.41M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.74M |
Top Sellers
| 1 | -$7.77M | |
| 2 | -$7.69M | |
| 3 | -$5.28M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.27M |
| 5 |
Morgan Stanley
New York
|
-$3.24M |